Shareholding21 Jul 2026, 05:30 pm
Gujarat Themis Biosyn: Promoter Group Creates Indirect Encumbrance
AI Summary
Gujarat Themis Biosyn Limited (GTBL) has disclosed an indirect encumbrance on 47.02% of its equity share capital, held by its promoter group entity, Pharmaceutical Business Group (India) Limited (PBGIL). This encumbrance arises from a pledge of 51% and a non-disposal undertaking over 47.98% of PBGIL's shares by Vividhmargi Investments Private Limited (VIPL) in favor of CTL Trusteeship Limited. The disclosure was made under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, following the creation of these instruments on June 29, 2026, in connection with a debenture trust deed.
Key Highlights
- Indirect encumbrance created on 47.02% of GTBL shares.
- Encumbrance stems from pledge and non-disposal undertaking on PBGIL shares.
- Disclosure made under SEBI Takeover Regulations.
- CTL Trusteeship Limited is the beneficiary of the encumbrance.
Price Impact
More from GUJTHEM